By The Online Investor Staff, updated Fri., Dec. 19, 6:23 PM
Slide #1. PlasmaTech Biopharmaceuticals, Inc. — Initial Public Offering
||PlasmaTech Biopharmaceuticals, Inc.
||PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: PTBI, PTBIW), a biopharmaceutical company advancing patient care in critical areas, announced the pricing of an underwritten public offering of 3,500,000 shares of common stock, and warrants to purchase up to an aggregate 3,500,000 shares of common stock, at an offering price of $4.00 per share and $.01 per warrant. The warrants have a per share exercise price of $5.00, are exercisable immediately, and expire 5 years from the date of issuance. The shares and warrants will begin trading on The NASDAQ Capital Market on December 19, 2014 under the symbols "PTBI" and "PTBIW," respectively.
IPOs: PlasmaTech Biopharmaceuticals, Inc.
List of IPOs in this Slideshow:
Company Ticker IPO Date
Neff Corporation NEFF
Peak Resorts SKIS
Avolon Holdings Limited AVOL
Great Ajax Corp T.B.D.
OnCore Biopharma, Inc. T.B.D.
Histogenics Corporation HSGX
Momo Inc. MOMO
Rice Midstream Partners LP RMP
James River Group Holdings, Ltd. JRVR
Metaldyne Performance Group Inc. MPG
CB Pharma Acquisition Corp. CNLMU
Patriot National, Inc. T.B.D.
Medovex Corp. MDVX
PlasmaTech Biopharmaceuticals, Inc. PTBI
December 19, 2014 6:23 PM Eastern